Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical de...
ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-u...
Sandoz, a global leader in generic and biosimilar medicines, is pleased to announce the European Commission's (EC) approval of Pyzchiva® (biosimilar us...
CordenPharma, a global CDMO leader in the manufacturing of Drug Substance (APIs) complex modalities (such as peptides, oligos and lipids) and injectable Dr...
Agilent Technologies Inc. announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demon...
Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...
Observation: ACROBiosystems' relentless commitment to innovation and strategic partnerships underscores its pivotal role in advancing organoid research and...
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced th...
Leveraging dsm-firmenich’s high quality GMP CBD active pharmaceutical ingredient (API) and leading-edge formulation capabilities, chiefly its bioavai...
Bristol Myers Squibb (NYSE: BMY) has announced the European Commission's (EC) expanded approval of Reblozyl® (luspatercept) for the first-line ...
Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...
The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site’s existing bioconjugation ca...
The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria Malaria is a serious and potentially fatal paras...
Actylis, a global leader in the distribution of critical raw materials for the life sciences industry, has entered into a strategic agreement...
© 2025 Biopharma Boardroom. All Rights Reserved.
